sotalol has been researched along with Shock, Cardiogenic in 5 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case is described of cardiogenic shock that occurred following use of sotalol in a patient with severe left ventricular dysfunction." | 3.81 | Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy. ( Bergin, P; Kaye, DM; Mariani, JA; McGiffin, DC; Saxena, P; Stokes, MB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leslie, SD | 1 |
| Stokes, MB | 1 |
| Saxena, P | 1 |
| Mariani, JA | 1 |
| Kaye, DM | 1 |
| Bergin, P | 1 |
| McGiffin, DC | 1 |
| Gilewski, W | 1 |
| Bednarska, D | 1 |
| Sinkiewicz, W | 1 |
| Mulder, VC | 1 |
| Oudemans-Van Straaten, HM | 1 |
| Zandstra, DF | 1 |
| Franssen, EJ | 1 |
| Yorgun, H | 1 |
| Deniz, A | 1 |
| Aytemir, K | 1 |
5 other studies available for sotalol and Shock, Cardiogenic
| Article | Year |
|---|---|
Sotalol-associated cardiogenic shock in a patient with asymptomatic transient rate-related cardiomyopathy.
Topics: Aged; Anti-Arrhythmia Agents; Asymptomatic Diseases; Atrial Flutter; Humans; Male; Shock, Cardiogeni | 2013 |
Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Heart Ventricles; Heart-Assist Devices; Humans; Male; Midd | 2015 |
[Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol].
Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; P | 2009 |
Massive ingestion of cardiac drugs: toxicokinetic aspects of digoxin and sotalol during hemofiltration.
Topics: Aged; Anti-Arrhythmia Agents; Digoxin; Hemofiltration; Humans; Immunoglobulin Fab Fragments; Male; R | 2010 |
Cardiogenic shock secondary to combination of diltiazem and sotalol.
Topics: Cardiovascular Agents; Diltiazem; Drug Therapy, Combination; Humans; Male; Middle Aged; Shock, Cardi | 2008 |